While some data suggests that GAD65 autoantibodies may be a non-pathogenic epiphenomenon of autoimmune diseases [13, 15], they are nonetheless valuable as biomarkers for inflammatory processes [4]. This evidence concerns the gene GAD2 and autoimmune disease.